Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma

36Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Previous studies have revealed that carcinoma-associated fibroblasts communicate microenvironment-derived signals through chemokine/chemokine receptor interaction, resulting in carcinogenesis. C-C motif chemokine ligand 20 (CCL20)/C-C motif chemokine receptor 6 (CCR6) interactions are involved in the pathogenesis of colonic malignancies. The present study aimed to characterize the roles of CCL20/CCR6 and the extracellular signal-regulated kinase (ERK) signaling pathway in lung adenocarcinoma growth. Lung adenocarcinoma samples obtained at surgery were assessed for the expression, tissue localization and production of CCL20/CCR6. In addition, colony formation, ERK signaling and chemokine production were measured to assess the responsiveness of the A549 cell line to CCL20 stimulation. CCL20 and CCR6 were found to be highly expressed in the majority of samples in the recurrence group (76 and 66%, respectively). The staining indexes of CCL20 and CCR6 in the recurrence group were 149.3 and 134.4, respectively, which were significantly higher than those in the non-recurrence group (57.2 and 58.0, respectively); the protein and mRNA expression levels determined by western blot and reverse transcription-quantitative polymerase chain reaction were also found to be high in the recurrence group For A549 cells, the colony-forming capacity was increased by CCL20 stimulation, and this effect was dependent in part on ERK phosphorylation. Collectively, the findings suggest that CCR6 and CCL20 may serve a role in lung adenocarcinoma, leading to proliferation and migration via autocrine or paracrine mechanisms. The disruption of CCL20/CCR6 interactions may be a promising strategy for the treatment of cancer.

References Powered by Scopus

Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method

149963Citations
N/AReaders
Get full text

Global cancer statistics, 2002

17722Citations
N/AReaders
Get full text

Inflammation and cancer: Back to Virchow?

6792Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The CCL20-CCR6 axis in cancer progression

158Citations
N/AReaders
Get full text

Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis

82Citations
N/AReaders
Get full text

Modulation of the CCR6-CCl20 axis: A potential therapeutic target in inflammation and cancer

59Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhang, X. P., Hu, Z. J., Meng, A. H., Duan, G. C., Zhao, Q. T., & Yang, J. (2017). Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma. Oncology Letters, 14(6), 8183–8189. https://doi.org/10.3892/ol.2017.7253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

78%

Researcher 2

22%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

62%

Biochemistry, Genetics and Molecular Bi... 3

23%

Chemistry 1

8%

Neuroscience 1

8%

Save time finding and organizing research with Mendeley

Sign up for free